Compare Enzyme (MLN) vs Viction (VIC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Viction — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Viction trades at Rp374.08 (market cap Rp82,57M, Rp708,9M 24h volume). The key difference: Enzyme is the larger of the two by market cap, and Viction's supply is capped (127,6M / 210M VIC (61%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Viction for 38 Days on average.
| MLN | VIC | |
|---|---|---|
Market Cap | Rp134,13M | Rp82,57M |
Volume (24h) | Rp104,56M | Rp708,9M |
Circulating Supply | 3,3M MLN | 127,6M / 210M VIC (61%) |
Typical Hold Time | 29 Days | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Viction (VIC) is trading at Rp365.7 with a bearish technical signal, as moving averages indicate strong selling pressure while oscillators remain neutral. The current price is below key support levels, with resistance at Rp552 and Rp600. No major protocol updates or ecosystem developments were noted recently, and the token's circulating supply is 61% of its maximum.
Overall outlook is cautious due to bearish technicals and lack of fundamental catalysts. Key opportunities include potential rebounds from oversold conditions, but risks involve low liquidity and persistent selling pressure. Investors should monitor for any network upgrades or exchange listings that could improve sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Viction
Viction, formerly TomoChain, is a people-centric layer-1 blockchain offering zero-gas transactions and enhanced security to make Web3 easy and safe for everyone. Designed with a focus on user experience, Viction prioritizes zero-gas transactions, speed, security, and scalability to create a more secure and open world. Viction is driven by a mission to build a decentralized platform that empowers humanity to connect, collaborate, and create without limitations, envisioning a world where transparency, accessibility, and growth thrive.
Read more on VIC →
